Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 06/30/2021 (updated monthly) $1,419.0 (M)
Net Assets - Class A As of 06/30/2021 (updated monthly) $1,143.8 (M)

Positions As of 06/30/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 06/30/2021 (updated monthly) $32,324.42(M) $44,663.61(M)
P/B RatioAs of 06/30/2021 (updated monthly) 5.11 6.18
P/E Ratio (12-mo Forward)As of 06/30/2021 (updated monthly) 15.43 14.18
Price to Cash FlowAs of 06/30/2021 (updated monthly) 16.84 16.64

Portfolio Details

Asset AllocationAs of 06/30/2021

[name] [value]
Equity 99.48%
Cash & Cash Equivalents 0.52%

Geographic BreakdownAs of 06/30/2021

[name] [value]
United States 92.74%
Denmark 2.07%
Canada 1.98%
Switzerland 1.49%
Netherlands 1.20%
Cash & Cash Equivalents 0.52%

sector breakdownAs of 06/30/2021

[name] [value]
Biotechnology 78.96%
Pharmaceuticals 11.89%
Life Sciences Tools & Services 6.94%
Diversified Capital Markets 0.85%
Other Diversified Financial Services 0.68%
Cash & Cash Equivalents 0.52%
Health Care Facilities 0.15%

TOP TEN HOLDINGSAs of 06/30/2021

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.74%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.47%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.44%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.03%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.67%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.62%
HORIZON PHARMA PLC United States Pharmaceuticals, Biotechnology & Life Sciences 3.22%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.16%
JAZZ PHARMACEUTICALS PLC United States Pharmaceuticals, Biotechnology & Life Sciences 2.78%
MIRATI THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.77%

Market Capitalization BreakdownAs of 06/30/2021

[name] [value]
<2.0 Billion 22.26%
2.0-5.0 Billion 15.18%
5.0-10.0 Billion 13.90%
10.0-25.0 Billion 14.47%
>50.0 Billion 32.84%
N/A 1.36%